Ro is a patient-driven telehealth company that aims to be a patient’s first call for all of their healthcare needs.
Ro uses technology to empower physicians to provide high-quality, affordable care when and where patients need it most.
Ro was founded in 2017 by Zachariah Reitano, Saman Rahmanian and Rob Schutz. The company is heaquartered in New York, New York.
Ro enables you to connect with a doctor and get treatment when and where you need it.
Ro builds technology to power three digital health clinics — Roman for men’s health, Rory for women’s health, and Zero for fighting smoking cessation — as well as Ro Pharmacy, an online pharmacy where every generic medication is $5 per month.
Ro’s platform makes healthcare more efficient by collecting a patient’s history, highlighting common risk factors, flagging contraindications, and consistently checking in with patients, giving physicians more time to spend addressing each patient’s unique needs.
Ro's nationwide network of physicians and pharmacies provides a personalized healthcare experience from online treatment to the delivery of medication and ongoing care. Ro’s also becoming a gateway into patient acquisition for primary care providers through Ribbon Health, and a test-case for the use of Pfizer’s Greenstone service, which provides certification that a generic drug is validated by one of the major pharmaceuticals.
Ro is backed by General Catalyst, FirstMark Capital, Torch, SignalFire, TQ Ventures, The Chernin Group, Initialized Capital, 3L, BoxGroup and others. The company raised $200M in Series C round on Jul 27, 2020. This brings Ro's total funding to $376.1M to date. The latest round gives the company a $1.5B valuation post-money.